Similar articles

Abstract: Objective: To investigate the association of serum lipids and other risk factors with diabetic retinopathy (DR) in Chinese type 2 diabetic patients. Methods: Five hundred and twenty-three type 2 diabetic patients underwent ophthalmic examination by experienced retinal specialists to assess their DR. serum lipids, including triglycerides, total cholesterol, high density lipoprotein cholesterol (HDLC), and low density lipoprotein cholesterol (LDLC), were measured using Roche automated clinical chemistry analyzers. The concentration of very low density lipoprotein cholesterol (VLDLC) was calculated based on total cholesterol, HDLC and LDLC. Hyperlipidemia was defined as a total cholesterol concentration of 6.2 mmol/L or higher or the use of lipid-lowering medications. The association of risk factors with any DR or proliferative diabetic retinopathy (PDR) was assessed using the odds ratio (OR) and its 95% confidence interval (CI), calculated from logistic regression models. Results: In multivariate logistic regression models, hyperlipidemia (OR=2.39, 95% CI: 1.02–5.66), higher VLDLC (OR=1.59, 95% CI: 1.14–2.23), and higher triglyceride (OR=1.18, 95% CI: 1.03–1.37) were associated with increased risk of DR. A longer diabetic duration was associated with increased risk of DR (P<0.0001) and PDR (P=0.002) in a dose-response manner. Higher systolic blood pressure (P=0.02) and higher serum creatinine (P=0.01) were independently associated with increased risk of DR, and female gender was associated with increased risk of PDR (P=0.03). Conclusions: Among Chinese type 2 diabetic patients, hyperlipidemia, higher VLDLC, and higher triglyceride were independently associated with increased risk of DR, suggesting control of serum lipids may decrease the risk of DR.

[1]Alberti, K.G.M.M., Zimmet, P.Z., Consultation, W., 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus—provisional report of a WHO consultation. Diabet. Med., 15(7):539-553.

[2]Cai, X.L., Wang, F., Ji, L.N., 2006. Risk factors of diabetic retinopathy in type 2 diabetic patients. Chin. Med. J., 119(10):822-826.

[3]Haffner, S.M., Mitchell, B.D., Moss, S.E., Stern, M.P., Hazuda, H.P., Patterson, J., van Heuven, W.A., Klein, R., 1993. Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? Ann. Epidemiol., 3(1):2-8.

[4]Lim, L.S., Wong, T.Y., 2012. Lipids and diabetic retinopathy. Exp. Opin. Biol. Ther., 12(1):93-105.

[5]Liu, D.P., Molyneaux, L., Chua, E., Wang, Y.Z., Wu, C.R., Jing, H., Hu, L.N., Liu, Y.J., Xu, Z.R., Yue, D.K., 2002. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res. Clin. Pract., 56(2):125-131.

[6]NHMRC (National Health and Medical Research Council of Australia), 1997. Clinical Practice Guidelines: Management of Diabetic Retinopathy. Commonwealth of Australia, p.1-94.

[7]Pang, C., Jia, L.L., Jiang, S.F., Liu, W., Hou, X.H., Zuo, Y.H., Gu, H.L., Bao, Y.Q., Wu, Q., Xiang, K.S., et al., 2012. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab. Res. Rev., 28(3):276-283.

[8]Raymond, N.T., Varadhan, L., Reynold, D.R., Bush, K., Sankaranarayanan, S., Bellary, S., Barnett, A.H., Kumar, S., O'Hare, J.P., Retinopath, U.A.D.S., 2009. Higher prevalence of retinopathy in diabetic patients of south Asian ethnicity compared with White Europeans in the community a cross-sectional study. Diabetes Care, 32(3):410-415.

[9]Wang, F.H., Liang, Y.B., Peng, X.Y., Wang, J.J., Zhang, F., Wei, W.B., Sun, L.P., Friedman, D.S., Wang, N.L., Wong, T.Y., et al., 2011. Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan eye study. Acta Ophthalmol., 89(4):E336-E343.

[10]Wang, S., Xu, L., Jonas, J.B., Wang, Y.X., You, Q.S., Yang, H., 2012. Dyslipidemia and eye diseases in the adult Chinese population: the Beijing eye study. PLoS One, 7(3):e26871.

[11]Wong, T.Y., Klein, R., Islam, A., Frances, M., Folsom, A.R., Klein, B.E., Sharrett, A.R., Shea, S., Athersclerosis, M.E.S., 2006. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am. J. Ophthalmol., 141(3):446-455.

[12]Xu, J., Wei, W.B., Yuan, M.X., Yuan, S.Y., Wan, G., Zheng, Y.Y., Li, Y.B., Wang, S., Xu, L., Fu, H.J., et al., 2012. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina, 32(2):322-329.

[13]Yang, W.Y., Lu, J.M., Weng, J.P., Jia, W.P., Ji, L.N., Xiao, J.Z., Shan, Z.Y., Liu, J., Tian, H.M., Ji, Q.H., et al., 2010. Prevalence of diabetes among men and women in China. N. Engl. J. Med., 362(12):1090-1101.

[14]Yau, J.W.Y., Rogers, S.L., Kawasaki, R., Lamoureux, E.L., Kowalski, J.W., Bek, T., Chen, S.J., Dekker, J.M., Fletcher, A., Grauslund, J., et al., 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3):556-564.